“…High-risk patients would benefit from obtaining titers, determining TA, and obtaining a hematology and/or anesthesiology consultation (3,4,14). If titers are as low as ,1:40 and TA is ,20 C, no further workup is needed (3,4). Management strategies include reduction of antibody levels through plasma exchange, administration of steroid, azathioprine, cyclophosphamide, or rituximab, in an effort to mitigate the likelihood of clinical significance (3,4).…”